BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 33360047)

  • 61. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial.
    Ejtahed HS; Tito RY; Siadat SD; Hasani-Ranjbar S; Hoseini-Tavassol Z; Rymenans L; Verbeke K; Soroush AR; Raes J; Larijani B
    Eur J Endocrinol; 2019 Mar; 180(3):165-176. PubMed ID: 30540558
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children.
    Gallardo-Becerra L; Cornejo-Granados F; García-López R; Valdez-Lara A; Bikel S; Canizales-Quinteros S; López-Contreras BE; Mendoza-Vargas A; Nielsen H; Ochoa-Leyva A
    Microb Cell Fact; 2020 Mar; 19(1):61. PubMed ID: 32143621
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial.
    Leong KSW; Jayasinghe TN; Wilson BC; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    JAMA Netw Open; 2020 Dec; 3(12):e2030415. PubMed ID: 33346848
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes.
    Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J
    Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women.
    Brahe LK; Le Chatelier E; Prifti E; Pons N; Kennedy S; Blædel T; Håkansson J; Dalsgaard TK; Hansen T; Pedersen O; Astrup A; Ehrlich SD; Larsen LH
    Br J Nutr; 2015 Aug; 114(3):406-17. PubMed ID: 26134388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
    de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
    Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oral supplementation with L-glutamine alters gut microbiota of obese and overweight adults: A pilot study.
    de Souza AZ; Zambom AZ; Abboud KY; Reis SK; Tannihão F; Guadagnini D; Saad MJ; Prada PO
    Nutrition; 2015 Jun; 31(6):884-9. PubMed ID: 25933498
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial.
    Madsen BS; Trebicka J; Thiele M; Israelsen M; Arumugan M; Havelund T; Krag A
    Trials; 2018 Feb; 19(1):143. PubMed ID: 29482588
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Causal Effects of Intensive Lifestyle and Metformin Interventions on Cardiovascular Disease Risk Factors in Pre-Diabetic People: An Application of G-Estimation.
    Salimi Y; Fotouhi A; Mohammad K; Mansournia N; Mansournia MA
    Arch Iran Med; 2017 Jan; 20(1):55-59. PubMed ID: 28112533
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children.
    Quiroga R; Nistal E; Estébanez B; Porras D; Juárez-Fernández M; Martínez-Flórez S; García-Mediavilla MV; de Paz JA; González-Gallego J; Sánchez-Campos S; Cuevas MJ
    Exp Mol Med; 2020 Jul; 52(7):1048-1061. PubMed ID: 32624568
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Profiles of gut microbiota in children with obesity from Harbin, China and screening of strains with anti-obesity ability in vitro and in vivo.
    Liang C; Guo M; Liu T; Zhou X; Gong P; Lyu L; Niu H; Wu Y; Chen S; Han X; Zhang L
    J Appl Microbiol; 2020 Sep; 129(3):728-737. PubMed ID: 32162449
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metformin Use in Children and Adolescents with Prediabetes.
    Khokhar A; Umpaichitra V; Chin VL; Perez-Colon S
    Pediatr Clin North Am; 2017 Dec; 64(6):1341-1353. PubMed ID: 29173789
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.
    Palacios T; Vitetta L; Coulson S; Madigan CD; Lam YY; Manuel R; Briskey D; Hendy C; Kim JN; Ishoey T; Soto-Giron MJ; Schott EM; Toledo G; Caterson ID
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32660025
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice.
    Lee H; Lee Y; Kim J; An J; Lee S; Kong H; Song Y; Lee CK; Kim K
    Gut Microbes; 2018 Mar; 9(2):155-165. PubMed ID: 29157127
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.
    Bridger T; MacDonald S; Baltzer F; Rodd C
    Arch Pediatr Adolesc Med; 2006 Mar; 160(3):241-6. PubMed ID: 16520442
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Childhood Obesity and Firmicutes/Bacteroidetes Ratio in the Gut Microbiota: A Systematic Review.
    Indiani CMDSP; Rizzardi KF; Castelo PM; Ferraz LFC; Darrieux M; Parisotto TM
    Child Obes; 2018; 14(8):501-509. PubMed ID: 30183336
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.
    Shin NR; Lee JC; Lee HY; Kim MS; Whon TW; Lee MS; Bae JW
    Gut; 2014 May; 63(5):727-35. PubMed ID: 23804561
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.
    Atabek ME; Pirgon O
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):339-48. PubMed ID: 18556965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.